Please login to the form below
heart attack
This page shows the latest heart attack news and features for those working in and with pharma, biotech and healthcare.
AstraZeneca’s Farxiga scores another FDA fast-track designation
or cardiovascular death in adult following an acute myocardial infarction or heart attack. ... secondary prevention of cardiovascular events among high-risk patients who have experienced a heart attack.
Latest news
-
AstraZeneca’s Brilinta reduces rate of secondary stroke
heart attack and/or death when given to patients who had previously suffered a stroke or transient transient ischaemic attack. ... The drug is already approved for the treatment of acute coronary syndrome (ACS) and for the secondary prevention of
-
Amarin shares tumble following Vascepa patent loss
treating indicated patients at high risk of cardiovascular events, such as heart attack and stroke,” said Thero.
-
Novartis plans inclisiran trial in the UK
Novartis also plans to conduct ORION-4, the ongoing study for patients who have already had a heart attack or stroke, with this study making the UK the global trial centre.
-
AZ says Brilinta hits the mark in new stroke trial
When used on its own by patients who had already suffered a stroke or transient ischaemic attack (TIA), it demonstrated a trend towards fewer subsequent events of stroke, heart attack ... The drug is already approved for the treatment of acute coronary
-
Novo Nordisk gets MACE prevention claim for Ozempic in US
of major adverse cardiovascular events (MACE) in type 2 diabetes patients with heart disease. ... fatal heart attack or non-fatal stroke by 26% versus placebo when added to standard of care.
More from news
Approximately 5 fully matching, plus 221 partially matching documents found.
Latest Intelligence
-
The evolution of marketing – the Amgen way
Yet, cardiovascular disease is still the leading cause of death in Europe, and 80% of premature cases of heart disease and stroke are preventable. ... predict which cardiovascular disease patients are at high risk of a second event, such as a heart attack
-
Changing direction: adapting to a rapidly-evolving environment
In the era of the algorithm, your doctor can now predict you’ll have a fatal heart attack five years before it hits you. ... If we’re going to exploit the brilliance of technology to change behaviours and transform health outcomes, marketing and
-
Insights from Cannes Lions Health Festival 2018
sea. He describes the impact – the pain, the chaos and the suffering – and we experience the attack with him through Jaws-style shots. ... The film ends with a big reveal: this wasn’t a shark attack, but a heart attack.
-
Proving real-world value
Insights reach R&D that ordinarily take years; beta-blockers, for example, found expanded use to control hypertension only after retrospective analysis of four decades of use in heart attack patients.”.
-
Why health psychology is the answer to tackling adherence
Therapy (OAP), a treatment that has been shown to reduce the risk of death or non-fatal heart attack.
More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.
Latest from PMHub
-
World Heart Day 2020: It's time to make our clinical trials more inclusive
One study found the average time for a South Asian patient to receive treatment for a heart attack was nearly double compared with a white person. ... For example, one study found that centrally located pain is symbolic of a heart attack in 87% white
-
Covid-19: what could it mean for the diabetic population?
a heart attack and twice as likely to have a stroke than people who do not have the condition. This, combined with the vast number of people affected by the disease,
-
Understanding the "Big Picture"
In this case, of the male patients with ACS, 27% experienced angina and 73% experienced a heart attack. ... This quickly demonstrates that the majority of male patients who experience a heart attack will be found within the non ST-elevated heart attack
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Lilly’s Verzenio scores a win in early-stage breast cancer
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
- Keytruda doubles five-year survival rate in NSCLC
- FDA approves Roche’s Actemra COVID-19 trial
- Novavax starts first phase 3 COVID-19 vaccine trial in the UK
PMHub
Blue Latitude Health
Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...
Latest intelligence
- Switzerland: a life sciences hub
- Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...
- Responding to dynamic shifts in value communications
- OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies....
- Doing what we can and having fun doing it: our fundraising month
- Charities are facing a number of challenges just to stay afloat amidst the current COVID-19 pandemic. Fundraisers are being cancelled and public donations are not as abundant as they have...
Quick links
Infographics
